3Vote!
PR News Wire (Free subscription) | 19/10/2009
ROCKLAND, Mass., Oct. 19 /PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, marked the expansion of its research facility in Billerica, MA today, with a topping off ceremony. Executives from EMD Serono were joined by Congresswoman Niki Tsongas, Gregory Bialecki, Secretary of Housing and Development, State Representative William Greene and Marc T. Lombardo, Chairman of...
3Vote!
Brass and Ivory (Free subscription) | 19/10/2009
Today's the big launch of a 'top secret' project which a few other bloggers and myself have been working on for the past couple of months. How I Fight MS Five people. One goal: to live victoriously with MS I like the concept of living victoriously with MS, because that is what we each strive to do I think. MS is not something we conquer but something with which we can live a positive life. The other...
3Vote!
Darmstadt (Free subscription) | 19/10/2009
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, marked the expansion of its research facility in Billerica, MA today, with a topping off ...
3Vote!
Red Orbit (Free subscription) | 19/10/2009
ROCKLAND, Mass., Oct. 19 /PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, marked the expansion of its research facility in Billerica, MA today, with a topping off ceremony.
3Vote!
ChinaTechNews.com (Free subscription) | 14/10/2009
China's State Food and Drug Administration has exposed five websites that were found selling medicines without proper approval. The websites are merckdx99.com which sells Moxue Xianfu'an in the name of Merck Serono China; bjtnbzl.com which sells Moke Huoyi Jiang Tang Tablet in the name of China Renhe Diabetes Research Institute; jksohu.com which sells Huoyi Shenjin Tablet [...]
3Vote!
Red Orbit (Free subscription) | 09/10/2009
TORONTO, Oct. 9 /PRNewswire/ - Background EMD Serono Canada, an affiliate of Merck Serono, Geneva, Switzerland, has launched a new probiotic multivitamin - Multibionta, a first of its kind for the Canadian market.
3Vote!
Business Wire (Free subscription) | 07/10/2009
TORONTO--(BUSINESS WIRE)--EMD Serono Canada has chosen Ariad Healthcare to be its lead marketing agency for Multibionta Probiotic Multivitamin, starting with 2010 commercialization strategies and programs. “The ability to drive high-level business strategy, combined with a track record of developing integrated, high-engagement programs, is what I value in Ariad”, says Greg Biehn, Business...
3Vote!
Business Wire (Free subscription) | 06/10/2009
NEW YORK--(BUSINESS WIRE)--German State of Hessen U.S. Office for Economic Development: German Life Science Speaker Panel and Networking Reception Welcome & Introduction: Dr. Horst Freitag, Consul General Speakers: Dr. Christian Garbe, Managing Director FIZ Frankfurt Biotechnology Innovation Center, Frankfurt, Germany Dr. Scott Lauder Global Head of Protein & Cell Sciences EMD Serono, Inc.,...
3Vote!
PR News Wire (Free subscription) | 05/10/2009
ROCKLAND, Mass., Oct. 5 /PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that Science magazine has named it one of the world's leading biotechnology and pharmaceutical employers. EMD Serono's ranking improved to No. 6 this year, up from No. 7 in 2008 and No. 17 in 2007.
5Vote!
Medical News Today (Free subscription) | 01/10/2009
EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for reducing relapses in people with relapsing forms of multiple sclerosis (MS).
3Vote!
PR News Wire (Free subscription) | 30/09/2009
ROCKLAND, Mass., Sept. 30 /PRNewswire/ -- EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, announced today the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for reducing relapses in people with relapsing forms of multiple sclerosis (MS)....
3Vote!
The Puget Sound Business Journal (Free subscription) | 28/09/2009
Seattle biotechnology company ZymoGenetics Inc. said Monday that Merck Serono SA had decided to halt studies of ZymoGenetics' drug candidate atacicept for treatment of multiple sclerosis. (ZGEN)
3Vote!
Seattle Times (Free subscription) | 28/09/2009
ZymoGenetics said Merck Serono has discontinued mid-stage studies of the Seattle company's drug atacicept in multiple sclerosis, after one study showed patients did worse with the treatment than without it.
3Vote!
Business Wire (Free subscription) | 28/09/2009
NEW YORK--(BUSINESS WIRE)--German State of Hessen U.S. Office for Economic Development: German Life Science Speaker Panel and Networking Reception Welcome & Introduction: Dr. Horst Freitag, Consul General Speakers: Dr. Christian Garbe, Managing Director FIZ Frankfurt Biotechnology Innovation Center, Frankfurt, Germany Dr. Scott Lauder Global Head of Protein & Cell Sciences EMD Serono, Inc.,...
Videos